Literature Survey for In-Vivo Reynolds and Womersley Numbers of Various Arteries and Implications for Compliant In-Vitro Modelling
Cardiovascular Engineering and Technology · 2024
DOI: 10.1007/s13239-024-00723-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Engineering and Technology, 2024. Verfasst von P N Williamson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, University of Canterbury, Private Bag 4800, Christchurch, 8140, New Zealand. Hauptthemen laut MEDLINE: Models, Cardiovascular, Arteries. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Canterbury.
Abstract (Originalsprache)
Purpose
In-vitro modelling can be used to investigate haemodynamics of arterial geometry and stent implants. However, in-vitro model fidelity relies on precise matching of in-vivo conditions. In pulsatile flow, velocity distribution and wall shear stress depend on compliance, and the Reynolds and Womersley numbers. However, matching such values may lead to unachievable tolerances in phantom fabrication.
Methods
Published Reynolds and Womersley numbers for 14 major arteries in the human body were determined via a literature search. Preference was given to in-vivo publications but in-vitro and in-silico values were presented when in-vivo values were not found. Subsequently ascending aorta and carotid artery case studies were presented to highlight the limitations dynamic matching would apply to phantom fabrication.
Results
Seven studies reported the in-vivo Reynolds and Womersley numbers for the aorta and two for the carotid artery. However, only one study each reported in-vivo numbers for the remaining ten arteries. No in-vivo data could be found for the femoral, superior mesenteric and renal arteries. Thus, information derived in-vitro and in-silico were provided instead. The ascending aorta and carotid artery models required scaling to 1.5× and 3× life-scale, respectively, to achieve dimensional tolerance restrictions. Modelling the ascending aorta with the comparatively high viscosity water/glycerine solution will lead to high pump power demands. However, all the working fluids considered could be dynamically matched with low pump demand for the carotid model.
Conclusion
This paper compiles available human haemodynamic information, and highlights the paucity of information for some arteries. It also provides a method for optimal in-vitro experimental configuration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mechanical Engineering, University of Canterbury, Private Bag 4800, Christchurch, 8140, New Zealand.
- Department of Mechanical Engineering, University of Canterbury, Private Bag 4800, Christchurch, 8140, New Zealand. paul.docherty@canterbury.ac.nz.
- Institute of Technical Medicine, Furtwangen University, Campus Villingen-Schwenningen, Jakob-Kienzle Strasse 17, 78054, Villingen-Schwenningen, Germany. paul.docherty@canterbury.ac.nz.
ORCID-Profile: P N Williamson, P D Docherty, M Jermy
Förderung
- University of Canterbury
Zitieren
APA
Williamson, P. N., Docherty, P. D., Jermy, M., & Steven, B. M. (2024). Literature Survey for In-Vivo Reynolds and Womersley Numbers of Various Arteries and Implications for Compliant In-Vitro Modelling. Cardiovascular Engineering and Technology. https://doi.org/10.1007/s13239-024-00723-4
Vancouver
Williamson PN, Docherty PD, Jermy M, Steven BM. Literature Survey for In-Vivo Reynolds and Womersley Numbers of Various Arteries and Implications for Compliant In-Vitro Modelling. Cardiovascular Engineering and Technology. 2024. doi:10.1007/s13239-024-00723-4
BibTeX
@article{Williamson2024,
author = {Williamson, P N and Docherty, P D and Jermy, M and Steven, B M},
title = {Literature Survey for In-Vivo Reynolds and Womersley Numbers of Various Arteries and Implications for Compliant In-Vitro Modelling},
journal = {Cardiovascular Engineering and Technology},
year = {2024},
doi = {10.1007/s13239-024-00723-4}
}
EUVIMED